TSH Rabbit Monoclonal Primary Antibody – Catalog #B2019807

TSH Rabbit Monoclonal Primary Antibody (Catalog #B2019807) is a high-affinity, high-specificity rabbit monoclonal antibody supplied as 1 mL liquid. It is designed for the sensitive and specific detection of human Thyroid-Stimulating Hormone (TSH) in immunoassays, immunohistochemistry, Western blotting, and other research applications. This antibody is an excellent tool for thyroid function studies, endocrine research, clinical assay development, and diagnostic reagent manufacturing.

Scientific Overview

This rabbit monoclonal antibody is raised against human Thyroid-Stimulating Hormone (TSH) and offers superior specificity and affinity compared to many polyclonal alternatives. It is ideal for quantitative detection of TSH in serum and plasma, as well as for localization studies in thyroid tissue. Rabbit monoclonal antibodies provide consistent performance, low background, and high reproducibility in ELISA, Western blot, IHC, and other immunoassay formats.

Key applications include:

• Quantitative TSH ELISA and immunoassay development
• Western blotting and immunoprecipitation of TSH
• Immunohistochemistry (IHC) and immunofluorescence (IF) on thyroid tissue
• Thyroid function research and endocrine diagnostics
• Clinical assay validation and reagent manufacturing

Usage & Handling Guidance

Store at -20°C. Avoid repeated freeze–thaw cycles. For ELISA and Western blotting, typical working dilution is 1:1,000–1:10,000 (optimize for your system). For IHC/IF, dilute in appropriate blocking buffer (e.g., 1–5% normal serum). Centrifuge briefly before use if precipitate is observed.

• Recommended starting dilution: 1:1,000–1:5,000 for most applications
• Blocking: Use normal goat or rabbit serum to minimize background
• Stability: Stable for months when stored properly at -20°C

What You Get

• 1 mL TSH Rabbit Monoclonal Primary Antibody (liquid format)
• High-affinity, high-specificity rabbit monoclonal reagent
• Ready for multiple immunoassay platforms
• Consistent performance across lots
• For research use only (RUO)

Why Researchers Choose It

• Rabbit monoclonal technology provides superior specificity and affinity
• Low background and high signal-to-noise ratio in sensitive assays
• Versatile across ELISA, Western blot, IHC, and IF applications
• Reliable tool for thyroid research and TSH assay development
• Consistent quality suitable for publication and diagnostic reagent work

Frequently Asked Questions (FAQ)

• What is the target of this antibody?
  It specifically recognizes human Thyroid-Stimulating Hormone (TSH).
• What applications is it suitable for?
  ELISA, Western blotting, IHC, IF, and other antibody-based detection methods.
• What dilution should I start with?
  1:1,000–1:5,000 for most applications; optimize for your specific assay and sample type.
• How should I store the antibody?
  Store at -20°C. Aliquot to avoid repeated freeze–thaw cycles.
• Is this antibody suitable for human samples?
  Yes. It is optimized for detection of human TSH in serum, plasma, and tissue.

---

References

• Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem. 1996 Jan;42(1):140-5.
• Rawlins ML, Roberts WL. Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin Chem. 2004 Dec;50(12):2338-2344.
• Szkudlinski MW, Fremont V, Ronin C, Weintraub BD. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev. 2002 Apr;82(2):473-502.
• Baluja Conde IB, Brito Moreno AI, Amores Sanchéz I, Acosta Bas C. Production and characterization of specific monoclonal antibodies of the human thyroid stimulating hormone. Hybridoma. 2000 Aug;19(4):335-8.
• Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, Nelson JC, Ronin C, Ross HA, Thijssen JH, Toussaint B. Report of the IFCC working group for standardization of thyroid function tests; part 1: thyroid-stimulating hormone. Clin Chem. 2010 Jun;56(6):902-11.
• Tozzoli R, Bagnasco M, Giavarina D, Bizzaro N. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. Autoimmun Rev. 2012 Dec;12(2):107-13.
• Bjerner J, Nustad K, Norum LF, Olsen KH, Børmer OP. Immunometric assay interferences: incidence and prevention. Clin Chem. 2002 Apr;48(4):613-21.
• Kricka LJ. Interferences in immunoassay — still a threat. Clin Chem. 2000 Aug;46(8):1037-8.
• Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489-499.
• Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14;291(2):228-238.